Arbutus Biopharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '25 Dec 3, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Market Capitalization	731	599	379	341	463	246	Upgrade
Market Cap Growth	17.00%	57.80%	11.19%	-26.27%	87.77%	60.15%	Upgrade
Enterprise Value	654	479	257	177	489	288	Upgrade
Last Close Price	3.70	3.03	2.27	2.12	3.23	2.90	Upgrade
PS Ratio	58.70	100.41	23.11	9.34	47.89	43.60	Upgrade
PB Ratio	11.08	6.36	3.95	2.66	3.11	2.96	Upgrade
P/TBV Ratio	11.08	6.36	3.95	2.66	3.11	-	Upgrade
EV/Sales Ratio	52.10	80.32	15.69	4.85	50.59	51.00	Upgrade
Debt / Equity Ratio	0.06	0.06	0.08	0.09	0.11	0.22	Upgrade
Asset Turnover	0.12	0.05	0.11	0.20	0.06	0.06	Upgrade
Quick Ratio	18.31	8.03	5.71	4.51	13.92	13.06	Upgrade
Current Ratio	18.80	8.15	5.87	4.60	14.32	13.39	Upgrade
Return on Equity (ROE)	-45.88%	-68.76%	-59.99%	-45.35%	-56.19%	-72.97%	Upgrade
Return on Assets (ROA)	-16.46%	-31.68%	-28.70%	-19.76%	-26.22%	-29.51%	Upgrade
Return on Capital (ROIC)	-20.03%	-40.08%	-36.93%	-23.40%	-28.63%	-32.60%	Upgrade
Return on Capital Employed (ROCE)	-33.90%	-60.30%	-64.00%	-38.90%	-37.10%	-44.90%	Upgrade
Earnings Yield	-4.93%	-11.28%	-17.38%	-19.05%	-14.49%	-21.15%	Upgrade
FCF Yield	-5.29%	-10.50%	-20.74%	-9.84%	-12.99%	-17.14%	Upgrade
Buyback Yield / Dilution	-5.88%	-11.84%	-9.95%	-42.07%	-40.10%	-32.83%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.